publication venue for
- Frataxin analysis using triple quadrupole mass spectrometry: application to a large heterogeneous clinical cohort.. 271:1844-1849. 2023
- Cortical thickness and cognition in older people with multiple sclerosis.. 270:5223-5234. 2023
- Multiple sclerosis optic neuritis and trans-synaptic pathology on cortical thinning in people with multiple sclerosis.. 270:3758-3769. 2023
- Correction to: Communicating the relevance of neurodegeneration and brain atrophy to multiple sclerosis patients: patient, provider and researcher perspectives.. 270:1120-1126. 2023
- Associations between neuropsychiatric symptoms and incident Alzheimer's dementia in men versus women.. 270:2069-2083. 2022
- Double blind trial of a deuterated form of linoleic acid (RT001) in Friedreich ataxia.. 270:1615-1623. 2022
- Toll-like receptors and NLRP3 inflammasome-dependent pathways in Parkinson's disease: mechanisms and therapeutic implications.. 270:1346-1360. 2022
- Optical coherence tomography (OCT) measurements and cognitive performance in multiple sclerosis: a systematic review and meta-analysis.. 270:1266-1285. 2022
- Communicating the relevance of neurodegeneration and brain atrophy to multiple sclerosis patients: patient, provider and researcher perspectives.. 270:1095-1119. 2022
- SARS-CoV-2 in patients with Friedreich ataxia.. 270:1-4. 2022
- Functional network dynamics and decreased conscientiousness in multiple sclerosis.. 269:2696-2706. 2021
- In vivo assessment of OXPHOS capacity using 3 T CrCEST MRI in Friedreich's ataxia.. 269:2527-2538. 2021
- Nucleus basalis of Meynert damage and cognition in patients with multiple sclerosis.. 268:4796-4808. 2021
- Visual deficits and cognitive assessment of multiple sclerosis: confounder, correlate, or both?. 268:2578-2588. 2021
- Diagnosis of depression in multiple sclerosis is predicted by frontal-parietal white matter tract disruption.. 268:169-177. 2020
- Seizures in Alzheimer's disease are highly recurrent and associated with a poor disease course.. 267:2941-2948. 2020
- Neurofilament light chain as a potential biomarker of disease status in Friedreich ataxia.. 267:2594-2598. 2020
- A protocol to reduce self-reported pain scores and adverse events following lumbar punctures in older adults.. 267:2002-2006. 2020
- A multimodal approach to assess the validity of atrophied T2-lesion volume as an MRI marker of disease progression in multiple sclerosis.. 267:802-811. 2019
- Regional variation in the incidence rate and sex ratio of multiple sclerosis in Scotland 2010-2017: findings from the Scottish Multiple Sclerosis Register.. 266:2376-2386. 2019
- Dietary and lifestyle factors in multiple sclerosis progression: results from a 5-year longitudinal MRI study.. 266:866-875. 2019
- Sleep disturbances are common in patients with autoimmune encephalitis.. 266:1007-1015. 2019
- Ocular amyloid imaging at the crossroad of Alzheimer's disease and age-related macular degeneration: implications for diagnosis and therapy.. 266:1566-1577. 2018
- Influence of glycaemic control on the outcomes of patients treated by intravenous thrombolysis for cerebral ischaemia.. 262:2504-12. 2015
- Late-life memory trajectories in relation to incident dementia and regional brain atrophy.. 262:2484-90. 2015
- Clinical, FDG and amyloid PET imaging in posterior cortical atrophy.. 262:1483-92. 2015
- Analysis of the visual system in Friedreich ataxia.. 260:2362-9. 2013
- New insights into Parkinson's disease.. III15-24. 2003
- Visual event-related potential changes in two subtypes of multiple system atrophy, MSA-C and MSA-P.. 249:975-82. 2002
- Visual event-related potentials in progressive supranuclear palsy, corticobasal degeneration, striatonigral degeneration, and Parkinson's disease.. 247:356-63. 2000